• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Precision Medicine Market Trends

    ID: MRFR/Pharma/0420-CR
    313 Pages
    Kinjoll Dey
    February 2021

    Precision Medicine Market Research Report By Application (Oncology, Cardiology, Neurology, Rare Diseases, Infectious Diseases), By Technology (Genomics, Proteomics, Metabolomics, Microbiomics, Bioinformatics), By End Use (Pharmaceutical Companies, Healthcare Institutions, Research Organizations, Diagnostic Laboratories), By Product (Diagnostic Tools, Therapeutics, Genetic Testing, Data Analytic...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Precision Medicine Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Precision Medicine Market

    Transformative trends in the market for precision medicine indicate a healthcare paradigm shift toward personalized, and targeted treatment approaches. One of the most significant observable trends is the inclusion of genetics and molecular diagnostics into precision medicine. The development of DNA sequencing technologies and molecular profiling has enabled medical practitioners to examine an individual’s genetic materials thus providing a more accurate approach to diagnosing diseases and suggesting the best possible treatments. Additionally, there is concentration on developing companion diagnostics as an essential part of precision medicine. These are tests that identify patients who are most likely to benefit from a particular therapeutic intervention making treatment targeted at such individuals only. This tendency indicates progression towards more stratified and precise patient selection during clinical trials and treatment regimens with outcomes optimization plus side effects minimization. Further, targeted therapies together with immunotherapies continue expanding within precision medicine market. Targeted therapies directly target specific molecular abnormalities associated with certain diseases while immunotherapies stimulate defence mechanism in body systems against disease like cancer. This trend is about moving away from uniform treatment approaches by providing patients with better accessible interventions based on their specific disease attributes. Besides, Artificial Intelligence (AI) and Machine Learning integration in precision medicine is another trend worth mentioning. AI algorithms can scrutinize huge amounts of data including genomic information, patient records, or clinical trial data sets for patterns identification on disease trajectories as well as suggest customized treatment strategies among many other things. Herein lies a trend towards data-driven predictive care which arms clinicians with useful decision support tools and aids in planning therapy. Again, the precision medicine market is becoming characterized by real-world evidence and decentralized clinical trials. Combining data from real-world settings with remote monitoring through digital networks provides better insights into the effectiveness of treatment and patients’ outcomes. This trend seeks to address problems associated with traditional clinical trial designs thereby resulting in stronger and more generalizable evidence about interventions for precision medicine.

    Market Summary

    As per Market Research Future Analysis, the Precision Medicine Market was valued at 30.30 USD Billion in 2024 and is projected to grow to 85.76 USD Billion by 2035, reflecting a CAGR of 9.92% from 2025 to 2035. The market is driven by the increasing prevalence of chronic diseases, advancements in genetic testing technologies, and significant government investments in healthcare innovation.

    Key Market Trends & Highlights

    Key trends driving the Precision Medicine Market include technological advancements and a focus on personalized healthcare.

    • Oncology market value in 2024: 25.0 USD Billion; projected to reach 85.76 USD Billion by 2035. Cardiology market value in 2024: 15.0 USD Billion; expected to grow to 32.0 USD Billion by 2035. Neurology segment valued at 10.0 USD Billion in 2024; anticipated to reach 22.0 USD Billion by 2035. Government investments through initiatives like the Precision Medicine Initiative are accelerating market growth.

    Market Size & Forecast

    2024 Market Size USD 30.30 Billion
    2035 Market Size USD 85.76 Billion
    CAGR (2025-2035) 9.92%
    Largest Regional Market Share in 2024 North America.

    Major Players

    <p>Key players include Pfizer, Thermo Fisher Scientific, Roche, AbbVie, Eli Lilly, Illumina, GSK, Johnson and Johnson, Biogen, Novartis, Bristol-Myers Squibb, Merck, AstraZeneca, Regeneron, and Amgen.</p>

    Market Trends

    Advances in genetic technology, more R&D spending, and a rising focus on individualized healthcare are some of the major factors propelling the global precision medicine market's notable expansion. Public-private sector cooperation has increased as pharmaceutical firms and healthcare providers realize the possibility of customizing medical treatments to each patient's unique genetic profile. In addition, the growing incidence of chronic illnesses and the demand for better treatment options are driving this focus on precision medicine. 

    Among the opportunities to be investigated is the use of machine learning and artificial intelligence in drug development procedures. By enhancing the accuracy of targeting particular patient categories, these technologies can lead to better treatment outcomes. Furthermore, there is a chance to support precision medicine research globally thanks to the expansion of biobanks and better access to massive datasets. There has also been a recent movement in the industry toward regulatory frameworks that facilitate the development and approval of precision medicine treatments. 

    Governments everywhere are realizing how crucial it is to modify regulations in order to possibly hasten the rollout of novel medicines. Furthermore, patients may now actively engage in their healthcare thanks to the development of digital health solutions like wearable technology and mobile health apps, which encourage the use of precision medicine. 

    Precision Medicine Market in the AI Sector

    As the healthcare industry makes a shift to more targeted treatment models, the inclusion of AI is rapidly advancing the precision medicine sector AI accelerates processes by assisting in the tailoring of healthcare to an individual’s patient’s genetics, environment, and lifestyle. With so much information to process, AI is also taught to expedite genomic information, electronic medical records, and medical images processing. This will help identify the intricate patterns while forecasting disease pathology.

    Among some of the most important contributions from AI are issues related to drug discovery, detecting tumors, diagnosing, as well as custom treatment protocols for diseases, but most importantly cancer therapy and inherited genetic diseases.

     

    <p>The Global Precision Medicine Market is poised for transformative growth, driven by advancements in genomics and personalized therapies that enhance patient outcomes and redefine treatment paradigms.</p>

    U.S. National Institutes of Health (NIH)

    Precision Medicine Market Market Drivers

    Market Trends and Forecasts

    Supportive Regulatory Environment

    A supportive regulatory framework significantly influences the growth of the Global Precision Medicine Market Industry. Governments and regulatory bodies are increasingly recognizing the importance of precision medicine in improving healthcare outcomes. Initiatives aimed at streamlining the approval process for personalized therapies and genetic tests encourage innovation and investment in this sector. This regulatory support not only fosters research and development but also enhances public trust in precision medicine solutions. As a result, the industry is poised for sustained growth, with stakeholders actively engaging in collaborative efforts to navigate regulatory landscapes.

    Technological Advancements in Genomics

    Technological innovations in genomics play a pivotal role in propelling the Global Precision Medicine Market Industry forward. The advent of next-generation sequencing and CRISPR technology has significantly reduced the cost and time associated with genetic testing. These advancements facilitate the identification of genetic markers linked to various diseases, enabling healthcare professionals to devise targeted therapies. As a result, the market is expected to expand, with projections indicating a value of 227.1 USD Billion by 2035. Such developments not only enhance diagnostic accuracy but also contribute to the overall effectiveness of treatment protocols.

    Increasing Prevalence of Chronic Diseases

    The rising incidence of chronic diseases globally serves as a critical driver for the Global Precision Medicine Market Industry. Conditions such as cancer, diabetes, and cardiovascular diseases necessitate innovative treatment strategies that precision medicine can provide. With the global population aging and lifestyle-related health issues on the rise, the demand for targeted therapies is expected to grow. This trend aligns with the anticipated compound annual growth rate of 7.41% from 2025 to 2035, highlighting the industry's potential to address complex health challenges through personalized approaches.

    Rising Demand for Personalized Treatments

    The Global Precision Medicine Market Industry experiences a notable surge in demand for personalized treatments, driven by advancements in genomics and biotechnology. Patients increasingly seek therapies tailored to their unique genetic profiles, which enhances treatment efficacy and minimizes adverse effects. This trend is reflected in the projected market value of 103.5 USD Billion in 2024, indicating a robust growth trajectory. As healthcare providers adopt precision medicine approaches, the industry is likely to witness a shift towards more individualized care, aligning with the growing emphasis on patient-centered healthcare solutions.

    Growing Investment in Research and Development

    Investment in research and development is a crucial driver for the Global Precision Medicine Market Industry. Increased funding from both public and private sectors facilitates the exploration of novel therapeutic approaches and technologies. This financial backing enables researchers to delve into the complexities of diseases at a molecular level, leading to breakthroughs in precision medicine. As the industry evolves, the emphasis on R&D is likely to yield innovative solutions that address unmet medical needs. Consequently, this investment trend is expected to contribute to the overall expansion of the market.

    Market Segment Insights

    Precision Medicine Market Application Insights

    <p>The Global Precision Medicine Market is witnessing a notable transformation with a focus on various applications essential to healthcare advancements. In 2024, the market was valued at 103.51 USD Billion, with significant contributions from different application sectors. One of the most prominent is Oncology, which holds a substantial market value of 25.0 USD Billion in 2024 and is projected to expand to 55.0 USD Billion by 2035.&nbsp;</p>

    <p>Oncology's importance stems from the rising prevalence of cancer globally, driving demand for targeted therapies and facilitating highly personalized treatment plans that greatly improve patient outcomes. In addition to Oncology, Cardiology is another key player in the market, valued at 15.0 USD Billion in 2024 and anticipated to grow to 32.0 USD Billion by 2035. With cardiovascular diseases being a leading cause of mortality worldwide, precision medicine in cardiology focuses on genetic testing and personalized treatment strategies to enhance patient care, thus holding a significant position in the Global Precision Medicine Market.</p>

    <p>Furthermore, the Neurology segment, valued at 10.0 USD Billion in 2024 and expected to reach 22.0 USD Billion by 2035, is increasingly important due to the rising incidences of neurological disorders such as Alzheimer's and Parkinson's diseases.&nbsp;</p>

    Precision Medicine Market Technology Insights

    <p>The Global Precision Medicine Market revenue is poised for significant growth, was valued at 103.51 USD Billion by 2024 and further expand to 227.13.0 USD Billion by 2035. The Technology segment of this market encompasses various critical components, showcasing immense potential. Among these, Genomics plays a vital role in understanding genetic profiles, enabling tailored treatments that enhance patient outcomes. Proteomics and Metabolomics are equally important, as they help in analyzing protein expressions and metabolic pathways, respectively, providing insights for targeted therapies.Microbiomics studies microbial communities, revealing their influence on health, thereby contributing valuable data for personalized medicine approaches.</p>

    <p>Bioinformatics supports these segments through advanced computational tools that analyze vast data sets, facilitating effective research and development processes. The Global Precision Medicine Market statistics highlight a growing need for innovative solutions driven by advancements in these technological areas, propelling market growth. However, challenges such as data privacy concerns and integration of diverse data types remain.Nevertheless, opportunities abound in harnessing big data and artificial intelligence to optimize healthcare solutions, ensuring that the industry continues to evolve and improve patient care globally.</p>

    Precision Medicine Market End Use Insights

    <p>The Global Precision Medicine Market is experiencing robust growth, valued at103.51 USD Billion in 2024, which reflects the increasing demand for personalized healthcare solutions. This market segmentation encompasses various essential areas, including Pharmaceutical Companies, Healthcare Institutions, Research Organizations, and Diagnostic Laboratories. Pharmaceutical Companies play a crucial role, as they invest heavily in the development of targeted therapies that align with precision medicine principles, addressing individual patient needs based on genetic information.Healthcare Institutions are increasingly adopting precision medicine practices to enhance patient outcomes through tailored treatment plans, thereby driving improvements in clinical efficacy.&nbsp;</p>

    <p>Research Organizations contribute significantly by advancing the scientific understanding of diseases, thus promoting innovation within the industry. Meanwhile, Diagnostic Laboratories serve as key facilitators, providing critical testing and analysis needed to identify suitable treatments for patients. Together, these segments comprise a vital ecosystem that supports the overarching goal of personalizing patient care, which underscores the importance of precision medicine in today's healthcare landscape.This growth is fueled by technological advancements, an increasing focus on chronic disease management, and evolving regulatory frameworks that favor more individualized approaches in medical treatment.</p>

    Precision Medicine Market Product Insights

    <p>The Global Precision Medicine Market is witnessing significant growth, was valued at 103.51 USD Billion by 2024. This market is primarily driven by advancements in personalized healthcare, emphasizing individual characteristics and genetic profiles. Within this landscape, the product segment encompasses various critical components such as Diagnostic Tools, Therapeutics, Genetic Testing, and Data Analytics Solutions. Diagnostic tools play a vital role in facilitating accurate disease detection, thus contributing to better treatment outcomes.</p>

    <p>Therapeutics offer tailored treatment options that enhance efficacy and minimize side effects for patients. Genetic testing is becoming increasingly important as it aids clinicians in understanding patient-specific disease risks and treatment responses, while data analytics solutions are essential for integrating vast amounts of healthcare data to derive actionable insights.</p>

    <p>With the ongoing focus on personalized treatments and an increasing volume of healthcare data, the Global Precision Medicine Market segmentation reflects a robust growth trajectory and presents several opportunities for innovation within each of its categories.The landscape is further propelled by the rise of personalized healthcare initiatives globally, driving the need for products that cater specifically to individual health requirements.</p>

    Get more detailed insights about Precision Medicine Market Research Report - Global Forecast till 2035

    Regional Insights

    The Global Precision Medicine Market is poised for significant growth across various regions, with North America holding a majority share, projected to reach a market valuation of 35.0 USD Billion in 2024 and expected to grow to 75.0 USD Billion by 2035. This dominance is attributable to advanced healthcare infrastructure, high R investment, and a strong presence of key players. Europe follows with substantial growth, anticipated to increase from 15.0 USD Billion in 2024 to 35.0 USD Billion by 2035, driven by rising healthcare expenditures and a growing elderly population.

    The Asia-Pacific (APAC) region, while starting at 12.0 USD Billion in 2024, is gaining traction, with expectations to double to 25.0 USD Billion by 2035, reflecting an increasing demand for personalized healthcare solutions supported by government initiatives. South America and the Middle East and Africa (MEA) are smaller markets, valued at 4.0 USD Billion and 3.5 USD Billion in 2024, respectively, but they present opportunities for growth due to expanding healthcare access and technological advancements.

    Collectively, these regional dynamics contribute significantly to the Global Precision Medicine Market statistics, enabling tailored treatment approaches that cater to the specific demographics and needs of each region.

    Precision Medicine Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Precision Medicine Market has been growing rapidly as a result of advancements in technology and an increased understanding of genomic medicine. This market focuses on tailoring medical treatment to individual characteristics, genetic profiles, and environmental factors, making healthcare more effective and personalized. Competitive dynamics within this sector are driven by the continuous innovation of therapies, diagnostic tools, and technologies that enable more informed decision-making in patient care.

    Companies are investing heavily in research and development to distinguish themselves, with collaboration and mergers playing a significant role in gaining competitive advantages. A strong pipeline of new products, along with strategic partnerships, is essential for companies aiming to capture market share in this evolving landscape.Pfizer has established a significant presence in the Global Precision Medicine Market by leveraging its extensive portfolio and robust research and development infrastructure. The company utilizes its strengths in drug development, particularly in oncology and rare diseases, to incorporate precision medicine principles into its therapeutic offerings. 

    Pfizer's commitment to understanding the genetic landscape informs its approach to personalized therapies, enabling the delivery of tailored treatments that optimize patient outcomes. Their strategic collaborations with academic institutions and biotech firms enhance their capability to innovate and adapt to changing market demands, reinforcing their competitive position within this emerging field.Thermo Fisher Scientific has made substantial contributions to the Global Precision Medicine Market through its comprehensive range of products and services designed for life sciences research and diagnostics. 

    The company specializes in advanced instruments, reagents, and consumables that are crucial for genomic analysis and molecular profiling, empowering researchers and clinicians to advance precision medicine initiatives. Thermo Fisher's strengths lie in its robust technological platform and extensive global reach, ensuring accessibility to its innovations. The company has pursued growth through strategic mergers and acquisitions, broadening its capabilities and product offerings in areas pertinent to precision medicine. This strategic positioning enables Thermo Fisher Scientific to remain competitive and relevant as the demand for personalized healthcare solutions continues to rise across the globe.

    Key Companies in the Precision Medicine Market market include

    Industry Developments

    Valo Health: Long-term Partnership with nference to Accelerate Human-Centric Drug Discovery: Valo Health announced a multi-year collaboration with nference in March 2025. This partnership will leverage decades of comprehensive, de-identified patient-level data from nference's federated AI network to enhance Valo's Opal Computational Platform™. This aims to advance the discovery and development of drug targets and precision medicines by integrating real-world patient insights. February 2025)

    Atomwise: Appoints Steve Worland, Ph.D. as CEO: Atomwise, a leader in leveraging ML/AI for small molecule drug discovery, announced the appointment of Steve Worland as its new CEO in February 2025. This appointment signifies a strategic move to accelerate the company's next phase of growth in AI-enabled drug discovery. (February 2025)

    Recent news developments in the Global Precision Medicine Market reflect a dynamic landscape characterized by significant advancements and collaborations. Notably, in October 2023, Pfizer and BioNTech announced a partnership to develop mRNA-based therapies for various diseases, enhancing their footprint in personalized medicine. Simultaneously, Thermo Fisher Scientific unveiled new genomic solutions aimed at improving precision diagnostics, further driving market growth.

    Current affairs indicate that Roche has expanded its portfolio with innovative diagnostics technologies, focusing specifically on oncology precision medicine, while AbbVie has invested heavily in Research and Development of personalized therapies for autoimmune diseases. In September 2023, Illumina acquired Grail, enhancing its capabilities in early cancer detection and showcasing a trend of consolidation within the sector.

    Mergers and acquisitions have also been significant, with Bristol Myers Squibb acquiring Mirati Therapeutics in August 2023 to boost its oncology pipeline. Furthermore, AstraZeneca and Amgen have recently announced a collaboration aimed at integrating artificial intelligence into drug discovery processes.These developments illustrate the aggressive strategies companies are employing to capture market share and fulfill the growing demand for tailored healthcare solutions globally. The market's valuation has seen robust growth, significantly impacting healthcare delivery through innovative therapies and diagnostics.

    Future Outlook

    Precision Medicine Market Future Outlook

    <p>The Precision Medicine Market is projected to grow at a 9.92% CAGR from 2025 to 2035, driven by advancements in genomics, personalized therapies, and increased healthcare investments.</p>

    New opportunities lie in:

    • <p>Develop AI-driven platforms for personalized treatment plans. Invest in biobanking to enhance patient data accessibility. Create partnerships with tech firms for innovative diagnostic tools.</p>

    <p>By 2035, the Precision Medicine Market is expected to be a cornerstone of healthcare innovation and patient care.</p>

    Market Segmentation

    Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Precision Medicine Market End Use Outlook

    • Pharmaceutical Companies
    • Healthcare Institutions
    • Research Organizations
    • Diagnostic Laboratories

    Precision Medicine Market Product Outlook

    • Diagnostic Tools
    • Therapeutics
    • Genetic Testing
    • Data Analytics Solutions

    Precision Medicine Market Technology Outlook

    • Genomics
    • Proteomic
    • Metabolomics
    • Microbiomics
    • Bioinformatics

    Precision Medicine Market Application Outlook

    • Oncology
    • Cardiology
    • Neurology
    • Rare Diseases
    • Infectious Diseases

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 202330.30 (USD Billion)
    MARKET SIZE 2024103.51 (USD Billion)
    MARKET SIZE 2035227.13 (USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)9.92% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2023
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDPfizer, Thermo Fisher Scientific, Roche, AbbVie, Eli Lilly, Illumina, GSK, Johnson and Johnson, Biogen, Novartis, BristolMyers Squibb, Merck, AstraZeneca, Regeneron, Amgen
    SEGMENTS COVEREDApplication, Technology, End Use, Product, Regional
    KEY MARKET OPPORTUNITIESPersonalized drug development, Growth in genomics research, Advancements in biomarkers, Increasing adoption of AI, Rising demand for targeted therapies
    KEY MARKET DYNAMICSRising healthcare expenditure, Increasing prevalence of chronic diseases, Advances in genomic technologies, Growing demand for personalized therapies, Supportive government initiatives
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    Market Size 202430.30
    Market Size 202533.31
    Market Size 203585.76
    Base Year2024
    Market Forecast Period2025 - 2035

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Precision Medicine market?

    The Precision Medicine market is the expected increase in total market value of 85.76 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Precision Medicine market?

    Precision Medicine market size was valued at approximately 30.3 billion USD in 2024. This figure will reach 85.76 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Precision Medicine market?

    Precision Medicine market is expected to grow at a CAGR of 9.92% between 2025 and 2035.

    How much will the Precision Medicine market be worth by 2035?

    Precision Medicine market is expected to be worth of 85.76 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Precision Medicine market perform over the next 10 years?

    Over the next 10 years the Precision Medicine market is expected to shift from usd billion 30.3 to 85.76 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What will be the projected market size of the Global Precision Medicine Market by 2035?

    By 2035, the Global Precision Medicine Market is projected to reach a valuation of 227.13 billion USD.

    Which region is expected to dominate the Global Precision Medicine Market in 2024?

    North America is expected to dominate the Global Precision Medicine Market with a value of 35.0 billion USD in 2024.

    What will be the market value of the oncology segment in the Global Precision Medicine Market by 2035?

    The oncology segment is projected to be valued at 55.0 billion USD in the Global Precision Medicine Market by 2035.

    How will the cardiology application of the Global Precision Medicine Market grow by 2035?

    The cardiology application is expected to grow to a valuation of 32.0 billion USD by 2035.

    Who are the key players in the Global Precision Medicine Market?

    Major players in the Global Precision Medicine Market include Pfizer, Roche, AbbVie, and Thermo Fisher Scientific.

    1. --- "
    2. Table of Contents
    3. EXECUTIVE SUMMARY
    4. Market Overview
    5. Key Findings
    6. Market Segmentation
    7. Competitive Landscape
    8. Challenges and Opportunities
    9. Future Outlook
    10. MARKET INTRODUCTION
    11. Definition
    12. Scope of the study
    13. Research Objective
    14. Assumption
    15. Limitations
    16. RESEARCH METHODOLOGY
    17. Overview
    18. Data Mining
    19. Secondary Research
    20. Primary Research
    21. Primary Interviews and Information Gathering Process
    22. Breakdown of Primary Respondents
    23. Forecasting Model
    24. Market Size Estimation
    25. Bottom-Up Approach
    26. Top-Down Approach
    27. Data Triangulation
    28. Validation
    29. MARKET DYNAMICS
    30. Overview
    31. Drivers
    32. Restraints
    33. Opportunities
    34. MARKET FACTOR ANALYSIS
    35. Value chain Analysis
    36. Porter's Five Forces Analysis
    37. Bargaining Power of Suppliers
    38. Bargaining Power of Buyers
    39. Threat of New Entrants
    40. Threat of Substitutes
    41. Intensity of Rivalry
    42. COVID-19 Impact Analysis
    43. Market Impact Analysis
    44. Regional Impact
    45. Opportunity and Threat Analysis
    46. Precision Medicine Market, BY Application (USD Billion)
    47. Oncology
    48. Cardiology
    49. Neurology
    50. Rare Diseases
    51. Infectious Diseases
    52. Precision Medicine Market, BY Technology (USD Billion)
    53. Genomics
    54. Proteomics
    55. Metabolomics
    56. Microbiomics
    57. Bioinformatics
    58. Precision Medicine Market, BY End Use (USD Billion)
    59. Pharmaceutical Companies
    60. Healthcare Institutions
    61. Research Organizations
    62. Diagnostic Laboratories
    63. Precision Medicine Market, BY Product (USD Billion)
    64. Diagnostic Tools
    65. Therapeutics
    66. Genetic Testing
    67. Data Analytics Solutions
    68. Precision Medicine Market, BY Regional (USD Billion)
    69. North America
    70. US
    71. Canada
    72. Europe
    73. Germany
    74. UK
    75. France
    76. Russia
    77. Italy
    78. Spain
    79. Rest of Europe
    80. APAC
    81. China
    82. India
    83. Japan
    84. South Korea
    85. Malaysia
    86. Thailand
    87. Indonesia
    88. Rest of APAC
    89. South America
    90. Brazil
    91. Mexico
    92. Argentina
    93. Rest of South America
    94. MEA
    95. GCC Countries
    96. South Africa
    97. Rest of MEA
    98. Competitive Landscape
    99. Overview
    100. Competitive Analysis
    101. Market share Analysis
    102. Major Growth Strategy in the Precision Medicine Market
    103. Competitive Benchmarking
    104. Leading Players in Terms of Number of Developments in the Precision Medicine Market
    105. Key developments and growth strategies
    106. New Product Launch/Service Deployment
    107. Merger & Acquisitions
    108. Joint Ventures
    109. Major Players Financial Matrix
    110. Sales and Operating Income
    111. Major Players R&D Expenditure. 2023
    112. Company Profiles
    113. Pfizer
    114. Financial Overview
    115. Products Offered
    116. Key Developments
    117. SWOT Analysis
    118. Key Strategies
    119. Thermo Fisher Scientific
    120. Financial Overview
    121. Products Offered
    122. Key Developments
    123. SWOT Analysis
    124. Key Strategies
    125. Roche
    126. Financial Overview
    127. Products Offered
    128. Key Developments
    129. SWOT Analysis
    130. Key Strategies
    131. AbbVie
    132. Financial Overview
    133. Products Offered
    134. Key Developments
    135. SWOT Analysis
    136. Key Strategies
    137. Eli Lilly
    138. Financial Overview
    139. Products Offered
    140. Key Developments
    141. SWOT Analysis
    142. Key Strategies
    143. Illumina
    144. Financial Overview
    145. Products Offered
    146. Key Developments
    147. SWOT Analysis
    148. Key Strategies
    149. GSK
    150. Financial Overview
    151. Products Offered
    152. Key Developments
    153. SWOT Analysis
    154. Key Strategies
    155. Johnson and Johnson
    156. Financial Overview
    157. Products Offered
    158. Key Developments
    159. SWOT Analysis
    160. Key Strategies
    161. Biogen
    162. Financial Overview
    163. Products Offered
    164. Key Developments
    165. SWOT Analysis
    166. Key Strategies
    167. Novartis
    168. Financial Overview
    169. Products Offered
    170. Key Developments
    171. SWOT Analysis
    172. Key Strategies
    173. BristolMyers Squibb
    174. Financial Overview
    175. Products Offered
    176. Key Developments
    177. SWOT Analysis
    178. Key Strategies
    179. Merck
    180. Financial Overview
    181. Products Offered
    182. Key Developments
    183. SWOT Analysis
    184. Key Strategies
    185. AstraZeneca
    186. Financial Overview
    187. Products Offered
    188. Key Developments
    189. SWOT Analysis
    190. Key Strategies
    191. Regeneron
    192. Financial Overview
    193. Products Offered
    194. Key Developments
    195. SWOT Analysis
    196. Key Strategies
    197. Amgen
    198. Financial Overview
    199. Products Offered
    200. Key Developments
    201. SWOT Analysis
    202. Key Strategies
    203. Appendix
    204. References
    205. Related Reports

    Precision Medicine Market Segmentation

    Precision Medicine Market By Application (USD Billion, 2019-2035)

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    Precision Medicine Market By Technology (USD Billion, 2019-2035)

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    Precision Medicine Market By End Use (USD Billion, 2019-2035)

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    Precision Medicine Market By Product (USD Billion, 2019-2035)

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    Precision Medicine Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Precision Medicine Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    North America Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    North America Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    North America Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    North America Precision Medicine Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    US Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    US Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    US Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    CANADA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    CANADA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    CANADA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    Europe Outlook (USD Billion, 2019-2035)

    Europe Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    Europe Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    Europe Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    Europe Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    Europe Precision Medicine Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    GERMANY Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    GERMANY Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    GERMANY Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    UK Outlook (USD Billion, 2019-2035)

    UK Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    UK Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    UK Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    UK Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    FRANCE Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    FRANCE Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    FRANCE Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    RUSSIA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    RUSSIA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    RUSSIA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    ITALY Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    ITALY Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    ITALY Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    SPAIN Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    SPAIN Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    SPAIN Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    REST OF EUROPE Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    REST OF EUROPE Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    REST OF EUROPE Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    APAC Outlook (USD Billion, 2019-2035)

    APAC Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    APAC Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    APAC Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    APAC Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    APAC Precision Medicine Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    CHINA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    CHINA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    CHINA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    INDIA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    INDIA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    INDIA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    JAPAN Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    JAPAN Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    JAPAN Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    SOUTH KOREA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    SOUTH KOREA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    SOUTH KOREA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    MALAYSIA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    MALAYSIA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    MALAYSIA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    THAILAND Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    THAILAND Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    THAILAND Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    INDONESIA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    INDONESIA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    INDONESIA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    REST OF APAC Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    REST OF APAC Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    REST OF APAC Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    South America Outlook (USD Billion, 2019-2035)

    South America Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    South America Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    South America Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    South America Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    South America Precision Medicine Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    BRAZIL Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    BRAZIL Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    BRAZIL Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    MEXICO Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    MEXICO Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    MEXICO Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    ARGENTINA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    ARGENTINA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    ARGENTINA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    REST OF SOUTH AMERICA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    REST OF SOUTH AMERICA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    REST OF SOUTH AMERICA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    MEA Outlook (USD Billion, 2019-2035)

    MEA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    MEA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    MEA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    MEA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    MEA Precision Medicine Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    GCC COUNTRIES Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    GCC COUNTRIES Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    GCC COUNTRIES Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    SOUTH AFRICA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    SOUTH AFRICA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    SOUTH AFRICA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Precision Medicine Market by Application Type

    Oncology

    Cardiology

    Neurology

    Rare Diseases

    Infectious Diseases

    REST OF MEA Precision Medicine Market by Technology Type

    Genomics

    Proteomics

    Metabolomics

    Microbiomics

    Bioinformatics

    REST OF MEA Precision Medicine Market by End Use Type

    Pharmaceutical Companies

    Healthcare Institutions

    Research Organizations

    Diagnostic Laboratories

    REST OF MEA Precision Medicine Market by Product Type

    Diagnostic Tools

    Therapeutics

    Genetic Testing

    Data Analytics Solutions

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027